족저근막염 치료 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

The global plantar fasciitis treatment market size is expected to reach USD 3.83 Billion in 2034 from USD 2.07 Billion in 2025, growing at a CAGR of 7.07% during 2026-2034.The Global Plantar Fasciitis Treatment Market is expanding due to the rising incidence of foot disorders, sports injuries, and obesity-related conditions. Plantar fasciitis is a common cause of heel pain, particularly among athletes and aging populations. Growing awareness about early diagnosis and treatment options such as orthotics, physiotherapy, medications, and minimally invasive procedures is supporting market growth. Increasing participation in physical activities also contributes to higher demand for treatment solutions.

Technological advancements in diagnostic imaging and therapeutic devices are key drivers for the market. The availability of innovative treatments, including shockwave therapy and regenerative medicine, is enhancing patient outcomes. Additionally, the increasing focus on non-surgical treatment methods and improved footwear technology is positively influencing demand. Healthcare providers are emphasizing preventive care and rehabilitation programs to reduce recurrence rates.

In the future, the market is expected to witness continued growth supported by advancements in biologics and personalized treatment approaches. Expanding healthcare infrastructure in emerging economies will further accelerate adoption. Rising healthcare expenditure and insurance coverage for musculoskeletal disorders will also play a vital role. As research in pain management and tissue regeneration progresses, the plantar fasciitis treatment market is poised for sustained development.

Our reports are carefully developed to deliver comprehensive and actionable insights across a wide range of industries and markets. Each report includes several essential components designed to provide a complete understanding of the market environment:

Market Overview: This section provides a clear introduction to the market, including key definitions, classifications, and an overview of the current industry landscape.

Market Dynamics: A detailed evaluation of the primary drivers, restraints, opportunities, and challenges shaping market growth. It covers factors such as technological developments, regulatory frameworks, and evolving industry trends.

Segmentation Analysis: A structured breakdown of the market into key segments based on product type, application, end-user, and geographic region. This section highlights the performance, growth potential, and contribution of each segment.

Competitive Landscape: An in-depth assessment of leading market participants, including their market positioning, product portfolios, strategic initiatives, and financial performance. It provides valuable insights into competitive dynamics and the strategies adopted by key players.

Market Forecast: Data-driven projections of market size and growth patterns over a defined forecast period. This section incorporates historical trends, current market conditions, and quantitative analysis to illustrate expected future developments.

Regional Analysis: A comprehensive review of market performance across major geographic regions, identifying high-growth areas and regional trends to better understand localized market opportunities.

Emerging Trends and Opportunities: Identification of significant market trends, technological advancements, and new investment opportunities. This section highlights potential growth areas and future industry developments.

Customization Options: We offer flexible customization services to tailor reports according to specific client requirements. This may include additional segmentation, country-level analysis, competitor profiling, customized data points, or focused insights on particular market segments to better support strategic decision-making.

MARKET SEGMENTATION

By Type

• Medication Therapy
• Orthotics
• Shockwave Therapy
• Surgery
• Others

By End User

• Hospitals
• Ambulatory Surgical Center
• Clinics
• Others

COMPANIES PROFILED

• Pfizer Inc., Algeo Ltd., Otto bock SE & Co., Hanger Inc., Bayer, GlaxoSmithKline Plc., Superfeet Worldwide Inc., Bauerfeid AG, KGaA (Otto bock Holding)., Sanofi, Group (Dr. Scholl's)

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL PLANTAR FASCIITIS TREATMENT MARKET: BY TYPE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Type
• 4.2. Medication Therapy Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Orthotics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Shockwave Therapy Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Surgery Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.6. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL PLANTAR FASCIITIS TREATMENT MARKET: BY END USER 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast End User
• 5.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Ambulatory Surgical Center Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL PLANTAR FASCIITIS TREATMENT MARKET: BY REGION 2022-2034 (USD MN)

• 6.1. Regional Outlook
• 6.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.2.1 By Type
  • 6.2.2 By End User
  • 6.2.3 United States
  • 6.2.4 Canada
  • 6.2.5 Mexico
• 6.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.3.1 By Type
  • 6.3.2 By End User
  • 6.3.3 United Kingdom
  • 6.3.4 France
  • 6.3.5 Germany
  • 6.3.6 Italy
  • 6.3.7 Russia
  • 6.3.8 Rest Of Europe
• 6.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.4.1 By Type
  • 6.4.2 By End User
  • 6.4.3 India
  • 6.4.4 Japan
  • 6.4.5 South Korea
  • 6.4.6 Australia
  • 6.4.7 South East Asia
  • 6.4.8 Rest Of Asia Pacific
• 6.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.5.1 By Type
  • 6.5.2 By End User
  • 6.5.3 Brazil
  • 6.5.4 Argentina
  • 6.5.5 Peru
  • 6.5.6 Chile
  • 6.5.7 Rest of Latin America
• 6.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.6.1 By Type
  • 6.6.2 By End User
  • 6.6.3 Saudi Arabia
  • 6.6.4 UAE
  • 6.6.5 Israel
  • 6.6.6 South Africa
  • 6.6.7 Rest of the Middle East And Africa

Chapter 7. COMPETITIVE LANDSCAPE

• 7.1. Recent Developments
• 7.2. Company Categorization
• 7.3. Supply Chain & Channel Partners (based on availability)
• 7.4. Market Share & Positioning Analysis (based on availability)
• 7.5. Vendor Landscape (based on availability)
• 7.6. Strategy Mapping

Chapter 8. COMPANY PROFILES OF GLOBAL PLANTAR FASCIITIS TREATMENT INDUSTRY

• 8.1. Top Companies Market Share Analysis
• 8.2. Company Profiles
  • 8.2.1 Pfizer Inc
  • 8.2.2 Algeo Ltd
  • 8.2.3 Otto Bock SE & Co
  • 8.2.4 Hanger Inc
  • 8.2.5 Bayer
  • 8.2.6 GlaxoSmithKline Plc
  • 8.2.7 Superfeet Worldwide Inc
  • 8.2.8 Bauerfeid AG
  • 8.2.9 KGaA (Otto Bock Holding)
  • 8.2.10 Sanofi
  • 8.2.11 Group (Dr. Scholl's)